Irina Dmitrievna Reshetnikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Irina Dmitrievna Reshetnikova has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Guzel Shavkhatovna Isaeva
Kazan Research Institute of Epidemiology and Microbiology; Kazan State Medical University
14 shared publications - Yuriy Aleksandrovich Tyurin
Kazan State Medical University
12 shared publications - Elena V. Agafonova
Kazan Research Institute of Epidemiology and Microbiology; Kazan State Medical University
9 shared publications - Tat'YAna A. Savitskaya
Kazan Research Institute of Epidemiology and Microbiology
7 shared publications - Aleksandra Vasilevna Ivanova
Russian Research Anti-Plague Institute “Microbe
6 shared publications - Vladimir A. Trifonov
Kazan Research Institute of Epidemiology and Microbiology
6 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 42-52
Epidemiological Situation on Hemorrhagic Fever with Renal Syndrome in 2025 in the World and in the Russian Federation, Incidence Forecast for 2026
The aim of this review is to describe the global epidemiological situation on hemorrhagic fever with renal syndrome (HFRS), provide a comparative analysis of the epidemiological situation on HFRS for 2000–2025 in the constituent entities and federal districts of the Russian Federation, and outline an incidence forecast for 2026. HFRS remains a widespread disease in the Western Pacific Region, Southeast Asia, and Europe. In the Russian Federation, the majority of HFRS cases are registered in the Volga Federal District, which accounts for over 80 % of all cases. In 2025, 4,912 cases of HFRS were diagnosed in the Russian Federation, a 31 % increase as compared to the previous year (3,396). The incidence rate (3.36 per 100,000 population) was below the long-term average for the period of 2013–2024, excluding 2020 and 2021 (5.06). There were 12 deaths (lethality rate – 0.24 %, mortality – 0.01 per 100,000 population). The epidemiological process was most active in the territory of 11 entities of the Volga Federal District: the Republic of Bashkortostan, the Udmurt Republic, Kirov, Samara, Penza, Nizhny Novgorod, Orenburg, Ulyanovsk Regions, the Mari El Republic, the Republic of Mordovia, and the Republic of Tatarstan. The review presents the results of epizootiological monitoring. For the purpose of forecasting and differentiating the areas by the level of incidence, epidemiological zoning of the entities of the Russian Federation was carried out based on the value of the potential epidemic risk indicator. Six groups of territories have been identified: those with an extremely high predicted risk, those with high, with above-average, average, low, and with minimal risk. Six regions are classified as having an extremely high prognostic risk of HFRS infection, including the Republic of Bashkortostan, the Republic of Mordovia, the Republic of Tatarstan, the Udmurt Republic, the Chuvash Republic, and the Yaroslavl Region.
- 22 July 2026
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 42-52
Open AccessEpidemiological Situation on Hemorrhagic Fever with Renal Syndrome in 2025 in the World and in the Russian Federation, Incidence Forecast for 2026
The aim of this review is to describe the global epidemiological situation on hemorrhagic fever with renal syndrome (HFRS), provide a comparative analysis of the epidemiological situation on HFRS for 2000–2025 in the constituent entities and federal districts of the Russian Federation, and outline an incidence forecast for 2026. HFRS remains a widespread disease in the Western Pacific Region, Southeast Asia, and Europe. In the Russian Federation, the majority of HFRS cases are registered in the Volga Federal District, which accounts for over 80 % of all cases. In 2025, 4,912 cases of HFRS were diagnosed in the Russian Federation, a 31 % increase as compared to the previous year (3,396). The incidence rate (3.36 per 100,000 population) was below the long-term average for the period of 2013–2024, excluding 2020 and 2021 (5.06). There were 12 deaths (lethality rate – 0.24 %, mortality – 0.01 per 100,000 population). The epidemiological process was most active in the territory of 11 entities of the Volga Federal District: the Republic of Bashkortostan, the Udmurt Republic, Kirov, Samara, Penza, Nizhny Novgorod, Orenburg, Ulyanovsk Regions, the Mari El Republic, the Republic of Mordovia, and the Republic of Tatarstan. The review presents the results of epizootiological monitoring. For the purpose of forecasting and differentiating the areas by the level of incidence, epidemiological zoning of the entities of the Russian Federation was carried out based on the value of the potential epidemic risk indicator. Six groups of territories have been identified: those with an extremely high predicted risk, those with high, with above-average, average, low, and with minimal risk. Six regions are classified as having an extremely high prognostic risk of HFRS infection, including the Republic of Bashkortostan, the Republic of Mordovia, the Republic of Tatarstan, the Udmurt Republic, the Chuvash Republic, and the Yaroslavl Region.
- 14 January 2026
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4
Detection of Reassortant Orthohantavirus puumalaense Strains in Vysokogorsky District, Republic of Tatarstan
The aim of the work was to detect Orthohantavirus puumalaense (PUUV) reassortant strains in bank voles (Clethrionomys glareolus) of the Republic of Tatarstan (RT), which are closely related to strains previously isolated from patients with hemorrhagic fever with renal syndrome (HFRS) from the RT. Materials and methods . Viral RNA was detected by RT-PCR in the lung tissue of bank voles captured in the Vysokogorsky and Pestrechinsky districts of the RT in 2023–2024. cDNA was synthesized for RT-PCR-positive samples. PUUV genome fragments of S- and M-segments were amplified using PCR, followed by sequencing (using the Sanger method and Oxford Nanopore technology) and phylogenetic analysis. Results and discussion . It has been found that 14 PUUV strains detected in bank voles from four capture sites fall into 3 clusters. In two strains from the vicinity of the village of Kinderi (cluster 2), a reassortant genome has been identified: the S-segment is closely related to strains from the Vysokogorsky district (nucleotide sequence (NS) identity is 99.1–100 %), while the M-segment is closely related to strains from the Pestrechinsky district (96.3–97.0 %). These virus strains are genetically close to reassortants previously found in HFRS patients infected by PUUV in the Vysokogorsky district of the RT. Detected in the vicinity of the village Kinderi PUUV strains appear to be of reassortant origin.
- 14 January 2026
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4
Detection of Reassortant Orthohantavirus puumalaense Strains in Vysokogorsky District, Republic of Tatarstan
The aim of the work was to detect Orthohantavirus puumalaense (PUUV) reassortant strains in bank voles (Clethrionomys glareolus) of the Republic of Tatarstan (RT), which are closely related to strains previously isolated from patients with hemorrhagic fever with renal syndrome (HFRS) from the RT. Materials and methods . Viral RNA was detected by RT-PCR in the lung tissue of bank voles captured in the Vysokogorsky and Pestrechinsky districts of the RT in 2023–2024. cDNA was synthesized for RT-PCR-positive samples. PUUV genome fragments of S- and M-segments were amplified using PCR, followed by sequencing (using the Sanger method and Oxford Nanopore technology) and phylogenetic analysis. Results and discussion . It has been found that 14 PUUV strains detected in bank voles from four capture sites fall into 3 clusters. In two strains from the vicinity of the village of Kinderi (cluster 2), a reassortant genome has been identified: the S-segment is closely related to strains from the Vysokogorsky district (nucleotide sequence (NS) identity is 99.1–100 %), while the M-segment is closely related to strains from the Pestrechinsky district (96.3–97.0 %). These virus strains are genetically close to reassortants previously found in HFRS patients infected by PUUV in the Vysokogorsky district of the RT. Detected in the vicinity of the village Kinderi PUUV strains appear to be of reassortant origin.
- Open Access
- 4 July 2025
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 17-28
Hemorrhagic Fever with Renal Syndrome: Current State of the Issue in the Russian Federation and Assessment of Epidemiological Risks for 2025
The results of epizootiological and epidemiological monitoring of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in 2024 and a forecast for 2025 are presented in the paper. In 2024, 3,396 cases of HFRS were registered in the Russian Federation (3.32 per 100 thousand population) – a decrease in the incidence of HFRS by 32.3 % as compared to previous year’s data was noted. The age structure of the patients was dominated by people aged 30–59 years (66.3 %, with some exceptions); 161 cases of the disease were observed among children under 17 years of age. The share of the male population was 72 %. The mortality rate was recorded at the level of 0.29 % – 10 lethal outcomes. In 2025, it is predicted that the tense epidemiological situation on HFRS will be retained in the constituent entities of the Volga and Central Federal Districts. Conditions for the occurrence of sporadic cases of HFRS will remain in the Northwestern, Ural, and Far Eastern Districts. Sporadic cases of the disease are possible in certain territories of the entities of the Southern, North Caucasian and Siberian Federal Districts. Proposals have been formulated to minimize possible epidemiological complications in the country for the forecasted period and the near future. The main areas of scientific developments aimed at improving the quality of epidemiological surveillance of HFRS, currently carried out using highly productive advanced technologies for data processing, analysis and visualization, are considered.
- 4 July 2025
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 17-28
Open AccessHemorrhagic Fever with Renal Syndrome: Current State of the Issue in the Russian Federation and Assessment of Epidemiological Risks for 2025
The results of epizootiological and epidemiological monitoring of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in 2024 and a forecast for 2025 are presented in the paper. In 2024, 3,396 cases of HFRS were registered in the Russian Federation (3.32 per 100 thousand population) – a decrease in the incidence of HFRS by 32.3 % as compared to previous year’s data was noted. The age structure of the patients was dominated by people aged 30–59 years (66.3 %, with some exceptions); 161 cases of the disease were observed among children under 17 years of age. The share of the male population was 72 %. The mortality rate was recorded at the level of 0.29 % – 10 lethal outcomes. In 2025, it is predicted that the tense epidemiological situation on HFRS will be retained in the constituent entities of the Volga and Central Federal Districts. Conditions for the occurrence of sporadic cases of HFRS will remain in the Northwestern, Ural, and Far Eastern Districts. Sporadic cases of the disease are possible in certain territories of the entities of the Southern, North Caucasian and Siberian Federal Districts. Proposals have been formulated to minimize possible epidemiological complications in the country for the forecasted period and the near future. The main areas of scientific developments aimed at improving the quality of epidemiological surveillance of HFRS, currently carried out using highly productive advanced technologies for data processing, analysis and visualization, are considered.
- 10 April 2025
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (1) , 11-22
T-cell immune response to SARS-CoV-2 in healthcare workers 2.5–3 years after COVID-19
BACKGROUND: The T cell adaptive immune response is an important factor in the formation of antiviral defense against SARS-CoV-2. AIM: Тo study T cell immunity to the SARS-CoV-2 in healthcare workers of a temporary infectious diseases hospital in Kazan — COVID-19 convalescents 2.5–3 years after the infection using the IGRA-ELISPOT technology. MATERIALS AND METHODS: The immune response to the most SARS-CoV-2 immunogenic peptides S, N, ORF-3a, ORF-7a was studied in 91 healthcare workers of the city of Kazan 2.5–3 years after suffering from COVID-19 of varying severity and varying vaccine status. The results were recorded by the number of formed spots: imprints of one T cell secreting interferon γ in response to antigenic stimulation. The number of obtained spots characterized the content of peripheral blood CD4+ and CD8+ T cells specific for SARS-CoV-2 antigens and made it possible to assess individual immune response. Statistical processing wasperformed using variation statistics methods using the statistical package Excel 2016 and WinPepi Version 11, 65. The relative frequency of a trait (P) and the error in the relative frequency value (m) were calculated. The study results were compared using the χ2-test when the number of observations was more than 5 and Fisher’s exact method when the number of observations was 5 or less. Differences were considered significant at p 0.05. RESULTS: 2.5–3 years after experiencing COVID-19 infection, T-cell immune response to S protein peptides is recorded in 72.53 ± 5.50 %, and to structural peptides N, M, ORF3a and ORF7a in 86.81 ± 3.81 % (χ2-test 5.733; p = 0.017) of medical workers. A higher level of T cell immunity to S protein peptides of the SARS-CoV-2 virus is observed in healthcare workers who have had moderate/severe COVID-19. The preservation of the parameters of hybrid immunity compared to post-infectious immunity is higher, which is significant both for groups with a history of clinical manifestations of COVID-19 and for the group with asymptomatic forms. CONCLUSION: Our empirically established ranking of the number of spots in classes can be used to assess individual cellular immunity and stratify the risks of re-infection in healthcare workers. A negative result of the T cell immune response to the spike S protein antigen may be the basis for deciding whether to re-vaccinate healthcare workers.
- 10 April 2025
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 22 (1) , 11-22
T-cell immune response to SARS-CoV-2 in healthcare workers 2.5–3 years after COVID-19
BACKGROUND: The T cell adaptive immune response is an important factor in the formation of antiviral defense against SARS-CoV-2. AIM: Тo study T cell immunity to the SARS-CoV-2 in healthcare workers of a temporary infectious diseases hospital in Kazan — COVID-19 convalescents 2.5–3 years after the infection using the IGRA-ELISPOT technology. MATERIALS AND METHODS: The immune response to the most SARS-CoV-2 immunogenic peptides S, N, ORF-3a, ORF-7a was studied in 91 healthcare workers of the city of Kazan 2.5–3 years after suffering from COVID-19 of varying severity and varying vaccine status. The results were recorded by the number of formed spots: imprints of one T cell secreting interferon γ in response to antigenic stimulation. The number of obtained spots characterized the content of peripheral blood CD4+ and CD8+ T cells specific for SARS-CoV-2 antigens and made it possible to assess individual immune response. Statistical processing wasperformed using variation statistics methods using the statistical package Excel 2016 and WinPepi Version 11, 65. The relative frequency of a trait (P) and the error in the relative frequency value (m) were calculated. The study results were compared using the χ2-test when the number of observations was more than 5 and Fisher’s exact method when the number of observations was 5 or less. Differences were considered significant at p 0.05. RESULTS: 2.5–3 years after experiencing COVID-19 infection, T-cell immune response to S protein peptides is recorded in 72.53 ± 5.50 %, and to structural peptides N, M, ORF3a and ORF7a in 86.81 ± 3.81 % (χ2-test 5.733; p = 0.017) of medical workers. A higher level of T cell immunity to S protein peptides of the SARS-CoV-2 virus is observed in healthcare workers who have had moderate/severe COVID-19. The preservation of the parameters of hybrid immunity compared to post-infectious immunity is higher, which is significant both for groups with a history of clinical manifestations of COVID-19 and for the group with asymptomatic forms. CONCLUSION: Our empirically established ranking of the number of spots in classes can be used to assess individual cellular immunity and stratify the risks of re-infection in healthcare workers. A negative result of the T cell immune response to the spike S protein antigen may be the basis for deciding whether to re-vaccinate healthcare workers.
- 15 April 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (1) , 43-54
Changes in the avids of IgG antibodies to the S protein of SARS-CoV-2 after coronavirus infection in medical workers of a temporary infections hospital
BACKGROUND: The effector capabilities of humoral immunity are determined not only by the amount of specific antibodies produced in response to an antigenic effect, but also by their qualitative characteristics, which include avidity ― the total strength of binding to the antigen, which determines the duration and effectiveness of post-infectious immunity to SARS-CoV-2. AIM: Is a selective study of the quantity and avidity of IgG antibodies to SARS-CoV-2 over time among medical workers of a temporary infectious diseases hospital in Kazan ― convalescents of COVID-19, during the period from July 2020 to July 2021. MATERIALS AND METHODS: Determination of IgG to the S antigen of SARS-CoV-2 by ELISA was carried out using the test system SARS-CoV-2-IgG quantitative-ELISA-BEST (Vector-Best, Russia) and expressed in BAU/ml (binding antibody units). Antibody avidity was determined using a 4.0 M urea solution and expressed as avidity indices. 1, 4 and 7 months after COVID-19 asymptomatic (n=34); mild severity (n=42); moderate severity (n=29); reinfected (n=34). When statistically processing the data, descriptive statistics methods and the Wilcoxon matched data test were used. Differences were considered significant at p 0.05. RESULTS: IgG avidity to SARS-CoV-2 depended on the severity of COVID-19. The highest rates of avidity indices were found in the group of those who had a moderate form of COVID-19. If in mild and asymptomatic forms there was a parallel decrease in avidity indices and IgG titer, then in moderate forms an increase in antibody titer was accompanied by a decrease in their avidity 4 months after the infection. 7 months after seroconversion, the IgG level decreased almost twofold, both in mild, asymptomatic and moderate forms. In the group of medical workers who had COVID-19 repeatedly, the initially low levels of avidity indices and antibody titers increased in parallel, while avidity indices after 7 months did not decrease, but remained high. Differences in avidity indices determined the subsequent formation of different trends in the development of the humoral immune response, which were mainly characterized by an uneven decrease in IgG and persistence of IgM antibodies for more than 1 month. CONCLUSIONS: The research results expand the understanding of the mechanisms of formation of the humoral immune response and the avidity of IgG antibodies against SARS-CoV-2 in the risk group ― medical workers. The level of humoral immunity decreases in the first six months and varies depending on the severity of COVID-19. The data obtained can be used to identify categories of increased risk of SARS-CoV-2 infection among healthcare workers, make decisions about immunorehabilitation and revaccination against COVID-19.
- 15 April 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (1) , 43-54
Changes in the avids of IgG antibodies to the S protein of SARS-CoV-2 after coronavirus infection in medical workers of a temporary infections hospital
BACKGROUND: The effector capabilities of humoral immunity are determined not only by the amount of specific antibodies produced in response to an antigenic effect, but also by their qualitative characteristics, which include avidity ― the total strength of binding to the antigen, which determines the duration and effectiveness of post-infectious immunity to SARS-CoV-2. AIM: Is a selective study of the quantity and avidity of IgG antibodies to SARS-CoV-2 over time among medical workers of a temporary infectious diseases hospital in Kazan ― convalescents of COVID-19, during the period from July 2020 to July 2021. MATERIALS AND METHODS: Determination of IgG to the S antigen of SARS-CoV-2 by ELISA was carried out using the test system SARS-CoV-2-IgG quantitative-ELISA-BEST (Vector-Best, Russia) and expressed in BAU/ml (binding antibody units). Antibody avidity was determined using a 4.0 M urea solution and expressed as avidity indices. 1, 4 and 7 months after COVID-19 asymptomatic (n=34); mild severity (n=42); moderate severity (n=29); reinfected (n=34). When statistically processing the data, descriptive statistics methods and the Wilcoxon matched data test were used. Differences were considered significant at p 0.05. RESULTS: IgG avidity to SARS-CoV-2 depended on the severity of COVID-19. The highest rates of avidity indices were found in the group of those who had a moderate form of COVID-19. If in mild and asymptomatic forms there was a parallel decrease in avidity indices and IgG titer, then in moderate forms an increase in antibody titer was accompanied by a decrease in their avidity 4 months after the infection. 7 months after seroconversion, the IgG level decreased almost twofold, both in mild, asymptomatic and moderate forms. In the group of medical workers who had COVID-19 repeatedly, the initially low levels of avidity indices and antibody titers increased in parallel, while avidity indices after 7 months did not decrease, but remained high. Differences in avidity indices determined the subsequent formation of different trends in the development of the humoral immune response, which were mainly characterized by an uneven decrease in IgG and persistence of IgM antibodies for more than 1 month. CONCLUSIONS: The research results expand the understanding of the mechanisms of formation of the humoral immune response and the avidity of IgG antibodies against SARS-CoV-2 in the risk group ― medical workers. The level of humoral immunity decreases in the first six months and varies depending on the severity of COVID-19. The data obtained can be used to identify categories of increased risk of SARS-CoV-2 infection among healthcare workers, make decisions about immunorehabilitation and revaccination against COVID-19.
- Open Access
- 4 April 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 113-124
Hantavirus Infections: Review of the Epidemiological Situation around the World. Analysis of the Epidemiological Situation on Hemorrhagic Fever with Renal Syndrome in the Russian Federation in 2023 and Forecast of Its Development for 2024
The paper describes the epidemiological situation in the countries of the world in terms of the incidence of Hantavirus diseases. The results of an epidemiological analysis of the incidence of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in 2023 by federal districts are presented and a forecast for 2024 is made. In 2023, 5 093 cases of HFRS were registered in the Russian Federation (3.47 per 100 thousand population). The incidence was reported in 7 out of 8 federal districts of the country. The age structure was dominated by people in the 30–59 age category (65.7 %); 247 cases of the disease were noted among children under 17 years of age. The proportion of the male population was 70.3 %. 63.2 % of the total number of cases was registered among the urban residents. The mortality rate was at the level of 0.49 % – 25 lethal outcomes. Analysis of the data has revealed a decrease in the incidence of HFRS in Russia by 27.2 % as compared to the previous year. However, the data from epizootiological monitoring and the results of laboratory research of field material indicate a continuing tense situation in the country as a whole. In a number of regions, a high risk of complications of the epidemiological situation is predicted (mainly, in the constituent entities of the Volga and Central Federal Districts). Moderate risks of developing local complications of the epidemiological situation at the level of long-term average morbidity are expected to be realized in the entities of the Northwestern, Ural and Far Eastern Federal Districts. Sporadic cases of the disease in the territory of the Southern Federal District are not excluded. The aggravation of the situation on HFRS in the territory of the North-Caucasian and Siberian Federal Districts is not anticipated in 2024.
- 4 April 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 113-124
Open AccessHantavirus Infections: Review of the Epidemiological Situation around the World. Analysis of the Epidemiological Situation on Hemorrhagic Fever with Renal Syndrome in the Russian Federation in 2023 and Forecast of Its Development for 2024
The paper describes the epidemiological situation in the countries of the world in terms of the incidence of Hantavirus diseases. The results of an epidemiological analysis of the incidence of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in 2023 by federal districts are presented and a forecast for 2024 is made. In 2023, 5 093 cases of HFRS were registered in the Russian Federation (3.47 per 100 thousand population). The incidence was reported in 7 out of 8 federal districts of the country. The age structure was dominated by people in the 30–59 age category (65.7 %); 247 cases of the disease were noted among children under 17 years of age. The proportion of the male population was 70.3 %. 63.2 % of the total number of cases was registered among the urban residents. The mortality rate was at the level of 0.49 % – 25 lethal outcomes. Analysis of the data has revealed a decrease in the incidence of HFRS in Russia by 27.2 % as compared to the previous year. However, the data from epizootiological monitoring and the results of laboratory research of field material indicate a continuing tense situation in the country as a whole. In a number of regions, a high risk of complications of the epidemiological situation is predicted (mainly, in the constituent entities of the Volga and Central Federal Districts). Moderate risks of developing local complications of the epidemiological situation at the level of long-term average morbidity are expected to be realized in the entities of the Northwestern, Ural and Far Eastern Federal Districts. Sporadic cases of the disease in the territory of the Southern Federal District are not excluded. The aggravation of the situation on HFRS in the territory of the North-Caucasian and Siberian Federal Districts is not anticipated in 2024.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (2)
Epidemiological and clinical aspects of hemorrhagic fever with renal syndrome at the present stage
Эпидемиологические и клинические аспекты геморрагической лихорадки с почечным синдромом на современном этапе
- 1 January 2024
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 13 (2)
Open AccessEpidemiological and clinical aspects of hemorrhagic fever with renal syndrome at the present stage
Эпидемиологические и клинические аспекты геморрагической лихорадки с почечным синдромом на современном этапе
- 2 December 2023
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 20 (4) , 476-487
Quantitative and species changes in the local microbiota of the upper respiratory tract in allergic rhinitis
BACKGROUND: The role of local microflora in the pathogenesis of allergic rhinitis has not been sufficiently studied; therefore, the study of changes in the nasal microbiome is of interest from a scientific and practical point of view. AIM: To evaluate changes in the local microbiota of the nasal mucosa in patients with seasonal and year-round allergic rhinitis before and after pharmacological and allergen-specific therapy. MATERIALS AND METHODS: An observational retrospective single-center case-control study was conducted, which included 182 patients with allergic rhinitis. The groups were randomized according to the diagnosis (seasonal and year-round allergic rhinitis) and the therapy used: basic pharmacotherapy and allergen-specific (sublingual) immunotherapy. RESULTS: In total, 182 patients completed the study, of which 50 had seasonal allergic rhinitis, 51 had seasonal allergic rhinitis + atopic asthma (aged 7–42 years), and 81 had year-round allergic rhinitis, which included 29 aged 12–54 years and 52 with year-round allergic rhinitis + atopic asthma, aged 12–39 years. Patients with allergic rhinitis were divided into two subgroups: those who received basic therapy to achieve remission and those who received allergen-specific (sublingual) immunotherapy. After basic therapy, the abundance of Staphylococcus aureus in the local microbiota of the upper respiratory tract in patients with seasonal allergic rhinitis decreased by 1.4 times; in the allergen-specific (sublingual) immunotherapy group, its abundance more significantly decreased (3.9 times; p 0.05). In the group with year-round allergic rhinitis, the same pattern was noted. In the group with seasonal allergic rhinitis and year-round allergic rhinitis and the group with both allergen-specific (sublingual) immunotherapy and atopic asthma who received a full course of allergen-specific (sublingual) immunotherapy, the activation index of blood basophils by rSplA-proteinase S. aureus was reduced by 1.2–1.5 compared with the value in those who received basic pharmacotherapy. CONCLUSION: Patients with allergic rhinitis exhibited quantitative and qualitative significant changes in the microbiome of the upper respiratory tract mucosa, one of the consequences of which is the development of IgE-mediated sensitization to S. aureus products. Allergen-specific immunotherapy for patients with allergic rhinitis leads to decreased colonization of the nasal mucosa with S. aureus and decreased sensitization to rSplA proteinase.
- 2 December 2023
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 20 (4) , 476-487
Quantitative and species changes in the local microbiota of the upper respiratory tract in allergic rhinitis
BACKGROUND: The role of local microflora in the pathogenesis of allergic rhinitis has not been sufficiently studied; therefore, the study of changes in the nasal microbiome is of interest from a scientific and practical point of view. AIM: To evaluate changes in the local microbiota of the nasal mucosa in patients with seasonal and year-round allergic rhinitis before and after pharmacological and allergen-specific therapy. MATERIALS AND METHODS: An observational retrospective single-center case-control study was conducted, which included 182 patients with allergic rhinitis. The groups were randomized according to the diagnosis (seasonal and year-round allergic rhinitis) and the therapy used: basic pharmacotherapy and allergen-specific (sublingual) immunotherapy. RESULTS: In total, 182 patients completed the study, of which 50 had seasonal allergic rhinitis, 51 had seasonal allergic rhinitis + atopic asthma (aged 7–42 years), and 81 had year-round allergic rhinitis, which included 29 aged 12–54 years and 52 with year-round allergic rhinitis + atopic asthma, aged 12–39 years. Patients with allergic rhinitis were divided into two subgroups: those who received basic therapy to achieve remission and those who received allergen-specific (sublingual) immunotherapy. After basic therapy, the abundance of Staphylococcus aureus in the local microbiota of the upper respiratory tract in patients with seasonal allergic rhinitis decreased by 1.4 times; in the allergen-specific (sublingual) immunotherapy group, its abundance more significantly decreased (3.9 times; p 0.05). In the group with year-round allergic rhinitis, the same pattern was noted. In the group with seasonal allergic rhinitis and year-round allergic rhinitis and the group with both allergen-specific (sublingual) immunotherapy and atopic asthma who received a full course of allergen-specific (sublingual) immunotherapy, the activation index of blood basophils by rSplA-proteinase S. aureus was reduced by 1.2–1.5 compared with the value in those who received basic pharmacotherapy. CONCLUSION: Patients with allergic rhinitis exhibited quantitative and qualitative significant changes in the microbiome of the upper respiratory tract mucosa, one of the consequences of which is the development of IgE-mediated sensitization to S. aureus products. Allergen-specific immunotherapy for patients with allergic rhinitis leads to decreased colonization of the nasal mucosa with S. aureus and decreased sensitization to rSplA proteinase.
- Open Access
- 29 April 2023
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 85-95
Analysis of the Epidemiological Situation of Hemorrhagic Fever with Renal Syndrome in the Russian Federation in 2022 and Forecast of its Development for 2023
The paper provides the analysis of epidemiological process of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in the context of federal districts in 2022 and a forecast of the HFRS incidence for 2023. According to the results of the analysis, there was a three-fold increase in the morbidity rates of HFRS in Russia in 2022 as compared to the indicators of 2021. The evidence of epizootiological survey and laboratory studies in certain federal districts of the Russian Federation indicate the continuing tense epidemiological situation on HFRS. In a number of regions of the country, high risk of infection with HFRS is predicted due to the favorable natural and climatic conditions of the winter period 2022/2023 for reservoir hosts of pathogenic for humans Hantaviruses. The findings of infected rodents attest to a high probability of complication of the epidemiological situation in the territories of increased epidemic hazard as regards HFRS.
- 29 April 2023
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 85-95
Open AccessAnalysis of the Epidemiological Situation of Hemorrhagic Fever with Renal Syndrome in the Russian Federation in 2022 and Forecast of its Development for 2023
The paper provides the analysis of epidemiological process of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in the context of federal districts in 2022 and a forecast of the HFRS incidence for 2023. According to the results of the analysis, there was a three-fold increase in the morbidity rates of HFRS in Russia in 2022 as compared to the indicators of 2021. The evidence of epizootiological survey and laboratory studies in certain federal districts of the Russian Federation indicate the continuing tense epidemiological situation on HFRS. In a number of regions of the country, high risk of infection with HFRS is predicted due to the favorable natural and climatic conditions of the winter period 2022/2023 for reservoir hosts of pathogenic for humans Hantaviruses. The findings of infected rodents attest to a high probability of complication of the epidemiological situation in the territories of increased epidemic hazard as regards HFRS.